These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11443581)

  • 21. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence and significance of transfusion-transmitted virus infection in Iranian patients on maintenance hemodialysis.
    Kheradpezhouh M; Taremi M; Gachkar L; Aghabozorgi S; Khoshbaten M
    J Microbiol Immunol Infect; 2007 Apr; 40(2):106-11. PubMed ID: 17446957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation.
    Pelletier SJ; Raymond DP; Crabtree TD; Iezzoni JC; Sawyer RG; Hahn YS; Pruett TL
    Hepatology; 2000 Aug; 32(2):375-81. PubMed ID: 10915745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers.
    Marroquin CE; Marino G; Kuo PC; Plotkin JS; Rustgi VK; Lu AD; Edwards E; Taranto S; Johnson LB
    Liver Transpl; 2001 Sep; 7(9):762-8. PubMed ID: 11552208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SEN virus infection among patients on maintenance hemodialysis in southern Taiwan.
    Dai CY; Chuang WL; Chang WY; Chen SC; Sung MH; Hsieh MY; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Yu ML
    J Infect; 2005 Aug; 51(2):110-5. PubMed ID: 16038760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.
    Fujiwara K; Tanaka Y; Orito E; Ohno T; Kato T; Sugauchi F; Suzuki S; Hattori Y; Sakurai M; Hasegawa I; Ozasa T; Kanie F; Kano H; Ueda R; Mizokami M
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1343-7. PubMed ID: 15610306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma-glutamyltransferase activity in chronic dialysis patients and renal transplant recipients with hepatitis C virus infection.
    Souza JF; Longui CA; Miorin LA; Sens YA
    Transplant Proc; 2008 Jun; 40(5):1319-23. PubMed ID: 18589096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
    Perez RM; Ferreira AS; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    Clin Transplant; 2005 Oct; 19(5):622-5. PubMed ID: 16146553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
    Kaşifoğlu N; Us T; Akgün Y
    Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients.
    Pérez-Daga JA; Ramírez-Plaza C; Suárez MA; Santoyo J; Fernández-Aguilar JL; Aranda JM; Sánchez-Pérez B; González-Sánchez A; Alvárez A; Valle M; Bondía JA
    Transplant Proc; 2008 Nov; 40(9):2959-61. PubMed ID: 19010159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into SEN virus prevalence, transmission, and treatment in community-based persons and patients with liver disease referred to a liver disease unit.
    Wong SG; Primi D; Kojima H; Sottini A; Giulivi A; Zhang M; Uhanova J; Minuk GY
    Clin Infect Dis; 2002 Oct; 35(7):789-95. PubMed ID: 12228814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
    Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SEN virus prevalence among non-B and non-C hepatitis patients with high liver function tests in the south of Turkey.
    Serin MS; Koksal F; Oksuz M; Abayli B; Aslan G; Tezcan S; Yildiz C; Kayar B; Emekdas G
    Jpn J Infect Dis; 2005 Dec; 58(6):349-52. PubMed ID: 16377865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance.
    Humar A; Washburn K; Freeman R; Paya CV; Mouas H; Alecock E; Razonable RR;
    Liver Transpl; 2007 Oct; 13(10):1422-7. PubMed ID: 17902128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SEN virus infection.
    Sagir A; Kirschberg O; Heintges T; Erhardt A; Häussinger D
    Rev Med Virol; 2004; 14(3):141-8. PubMed ID: 15124231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan.
    Shibata M; Wang RY; Yoshiba M; Shih JW; Alter HJ; Mitamura K
    J Infect Dis; 2001 Aug; 184(4):400-4. PubMed ID: 11471096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
    Martinot-Peignoux M; Boyer N; Cazals-Hatem D; Pham BN; Gervais A; Le Breton V; Levy S; Degott C; Valla DC; Marcellin P
    Hepatology; 2001 Nov; 34(5):1000-5. PubMed ID: 11679971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
    Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
    J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.